Risks of bioidentical hormones

Sellers of compounded bio-identical hormones often claim that their products the risks of drugs approved by FDA for menopausal hormone therapy (MHT) The trial was stopped early, in 2002, because hormone users had a higher risk of breast cancer, heart disease, stroke, and blood clots. Though the added risks

1 Authority on Bioidentical Hormones John Lee M.D. describes three rules for real progesterone) increase a woman s risk of breast cancer by 30 percent or

Risks and effectiveness of compounded bioidentical hormone therapy: A case series. Journal of Women39s Health. 201423:642. Compounded menopausal Learn more about bioidentical hormone therapy and hormone testing from NAMS . hormones may provide certain benefitsbut there may be risks to the Non-bioidentical hormones are not identical in structure or activity to the an increased risk of breast cancer with the use of non-bioidentical progestins.1, 5,

Consumer Updates gt Bio-Identicals: Sorting Myths from Facts

9 Nov 2011 Frequently, patients ask if I prescribe bioidentical hormones. and, unlike FDA- pproved commercial hormones, have no risks or side effects Bioidentical hormones may also present extra risks, due to the process of compounding. In addition, the accuracy and efficacy of saliva testing has not been

15 Jan 2009 15, 2009 -- Oprah Winfrey says menopause caught her off guard and that she39s taking bioidentical hormones that have made a big Bio-identical hormones can offer welcome relief to debilitating menopause symptoms, but not without risk. Research is ongoing, but here39s what we know now